Clinical Trials Directory

Trials / Sponsors / Theratechnologies

Theratechnologies

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
CompletedThe Visceral Adiposity Measurement and Observation Study
HIV, HIV-Infections, HIV-1-infection
—2022-04-18
Active Not RecruitingA Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without I
HIV Infections, Multi-Antiviral Resistance
—2022-03-22
Active Not RecruitingTH1902 in Patients With Advanced Solid Tumors
Solid Tumor, TNBC - Triple-Negative Breast Cancer, Hormone Receptor-positive Breast Cancer
Phase 12021-03-04
TerminatedLong-term Observational Study in HIV Subjects Exposed to EGRIFTA®
HIV
—2013-02-01
TerminatedDiabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Diabetic Retinopathy, HIV
Phase 42012-06-01
TerminatedEfficacy and Safety Study of Tesamorelin in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Muscle
Chronic Obstructive Pulmonary Disease (COPD)
Phase 22011-09-01
CompletedPharmacokinetic and Pharmacodynamic Study of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Positive
HIV
Phase 12008-05-01
CompletedTH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
Lipodystrophy, HIV Infections
Phase 32007-08-01
CompletedTH9507 in Patients With HIV-Associated Lipodystrophy
HIV Infections, Lipodystrophy
Phase 32005-06-01
CompletedSafety Study of TH9507 in Subjects With Stable, Type 2 Diabetes
Type 2 Diabetes
Phase 22002-02-01